日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Bridging paradigms and shaping the future of resectable gastric cancer: a narrative review of the post-MATTERHORN era

弥合范式差异,塑造可切除胃癌的未来:MATTERHORN 试验后时代的叙述性回顾

Okemoto, Dai; Nakayama, Izuma; Shitara, Kohei

CLDN18.2 in Gastric Cancer: Current Therapeutic Landscape and Future Perspectives

CLDN18.2在胃癌中的作用:当前治疗现状及未来展望

Zhang, Fei; Okazaki, Ukyo; Nakayama, Izuma; Shitara, Kohei

Nivolumab plus chemotherapy in Asian people with advanced or recurrent stomach or gastroesophageal junction cancer (ATTRACTION-4 study): a plain language summary

纳武利尤单抗联合化疗治疗亚洲晚期或复发性胃癌或胃食管交界处癌患者(ATTRACTION-4 研究):简明语言摘要

Chen, Li-Tzong; Kang, Yoon-Koo; Ryu, Min-Hee; Oh, Do-Youn; Oh, Sang Cheul; Rha, Sun Young; Lee, Keun-Wook; Omori, Takeshi; Shitara, Kohei; Sakuramoto, Shinichi; Chung, Ik-Joo; Yamaguchi, Kensei; Kato, Ken; Sym, Sun Jin; Kadowaki, Shigenori; Tsuji, Kunihiro; Chen, Jen-Shi; Bai, Li-Yuan; Oh, Sung-Yong; Choda, Yasuhiro; Yasui, Hisateru; Takeuchi, Kentaro; Hirashima, Yoshinori; Hagihara, Shunsuke; Boku, Narikazu

Nivolumab plus chemotherapy or ipilimumab in gastroesophageal cancer: exploratory biomarker analyses of a randomized phase 3 trial

纳武利尤单抗联合化疗或伊匹木单抗治疗胃食管癌:一项随机3期试验的探索性生物标志物分析

Shitara, Kohei; Janjigian, Yelena Y; Ajani, Jaffer; Moehler, Markus; Yao, Jin; Wang, Xuya; Chhibber, Aparna; Pandya, Dimple; Shen, Lin; Garrido, Marcelo; Gallardo, Carlos; Wyrwicz, Lucjan; Yamaguchi, Kensei; Skoczylas, Tomasz; Bragagnoli, Arinilda; Liu, Tianshu; Schenker, Michael; Yañez, Patricio; Kowalyszyn, Ruben; Karamouzis, Michalis; Zander, Thomas; Feeney, Kynan; Elimova, Elena; Doshi, Parul; Li, Mingshun; Lei, Ming

Microbiota-driven antitumour immunity mediated by dendritic cell migration

微生物群驱动的抗肿瘤免疫由树突状细胞迁移介导

Lin, Nina Yi-Tzu; Fukuoka, Shota; Koyama, Shohei; Motooka, Daisuke; Tourlousse, Dieter M; Shigeno, Yuko; Matsumoto, Yuki; Yamano, Hiroyuki; Murotomi, Kazutoshi; Tamaki, Hideyuki; Irie, Takuma; Sugiyama, Eri; Kumagai, Shogo; Itahashi, Kota; Tanegashima, Tokiyoshi; Fujimaki, Kaori; Ito, Sachiko; Shindo, Mariko; Tsuji, Takahiro; Wake, Hiroaki; Watanabe, Keisuke; Maeda, Yuka; Enokida, Tomohiro; Tahara, Makoto; Yamashita, Riu; Fujisawa, Takao; Nomura, Motoo; Kawazoe, Akihito; Goto, Koichi; Doi, Toshihiko; Shitara, Kohei; Mano, Hiroyuki; Sekiguchi, Yuji; Nakamura, Shota; Benno, Yoshimi; Nishikawa, Hiroyoshi

Lenvatinib Plus Pembrolizumab and Chemotherapy Versus Chemotherapy in Advanced Metastatic Gastroesophageal Adenocarcinoma: The Phase III, Randomized LEAP-015 Study

乐伐替尼联合帕博利珠单抗和化疗对比单纯化疗治疗晚期转移性胃食管腺癌:III期随机LEAP-015研究

Shitara, Kohei; Lorenzen, Sylvie; Li, Jin; Bai, Yuxian; Fernández, Manuel González; Aguilar, Mynor; Shoji, Hirokazu; Reyes-Cosmelli, Felipe; Peña, Yovany Rodriguez; Corrales, Luis; Wyrwicz, Lucjan; Eyzaguirre, Daniel Acosta; Pan, Yueyin; Ryu, Min-Hee; Cohen, Deirdre J; Wainberg, Zev A; Ku, Geoffrey; Tabernero, Josep; Van Cutsem, Eric; Qin, Shu-Kui; Oh, Do-Youn; Xu, Jianming; Liang, Li Wen; Bordia, Sonal; Bhagia, Pooja; Rha, Sun Young

Impact of Human Epidermal Growth Factor Receptor 2 in Patients With Metastatic Colorectal Cancer Treated With Chemotherapy Plus Bevacizumab or Anti-EGFRs: Exploratory Analysis of Eight Randomized Trials

人表皮生长因子受体2在接受化疗联合贝伐单抗或抗EGFR治疗的转移性结直肠癌患者中的影响:八项随机试验的探索性分析

Germani, Marco Maria; Borelli, Beatrice; Hashimoto, Tadayoshi; Nakamura, Yoshiaki; Oldani, Simone; Battaglin, Francesca; Bergamo, Francesca; Salvatore, Lisa; Stahler, Arndt; Antoniotti, Carlotta; Shitara, Kohei; Venook, Alan; Oki, Eiji; Muro, Kei; Ugolini, Clara; Soeda, Junpei; Lonardi, Sara; Pietrantonio, Filippo; Lenz, Heinz-Josef; Modest, Dominik Paul; Yoshino, Takayuki; Cremolini, Chiara

Atezolizumab following definitive chemoradiotherapy in patients with unresectable locally advanced esophageal squamous cell carcinoma - a multicenter phase 2 trial (EPOC1802).

在无法切除的局部晚期食管鳞状细胞癌患者中,接受根治性放化疗后使用阿特珠单抗治疗——一项多中心 2 期试验 (EPOC1802)

Bando Hideaki, Kumagai Shogo, Kotani Daisuke, Mishima Saori, Irie Takuma, Itahashi Kota, Tanaka Yosuke, Habu Takumi, Fukaya Sayuri, Kondo Masaki, Tsushima Takahiro, Hara Hiroki, Kadowaki Shigenori, Kato Ken, Chin Keisho, Yamaguchi Kensei, Kageyama Shun-Ichiro, Hojo Hidehiro, Nakamura Masaki, Tachibana Hidenobu, Wakabayashi Masashi, Fukui Makoto, Fuse Nozomu, Koyama Shohei, Mano Hiroyuki, Nishikawa Hiroyoshi, Shitara Kohei, Yoshino Takayuki, Kojima Takashi

Modeling and addressing on-target/off-tumor toxicity of claudin 18.2 targeted immunotherapies

对靶向 Claudin 18.2 的免疫疗法的靶内/脱靶毒性进行建模和分析

Carstens, Elizabeth J; Takahashi, Kazuki; Sakamoto, Naoya; De Vizio, Martina; Morgado, Micaela; Nikkhoi, Shahryar Khoshtinat; Mangipudi, Abhishek; Nguyen, Canh Hiep; Weltzin, Tate; Nakayama, Izuma; Lv, Qiang; Zeng, Jue; Nie, Cui; Deng, Changjing; Wang, Xiaoxiao; Liu, Lile; Klempner, Samuel J; Ramasubramanian, Anusuya; Nowak, Jonathan A; Aguirre, Andrew J; Shitara, Kohei; Smith, Eric L

Dynamic modulation of claudin18.2 expression and remodeling of the tumor microenvironment in gastric cancer during chemo-immunotherapy

化疗-免疫治疗期间胃癌中claudin18.2表达的动态调控及肿瘤微环境的重塑

Lim, Sung Hee; Kuwata, Takeshi; An, Minae; Hong, Jung Yong; Kim, Seung Tae; Matsubara, Yuki; Shitara, Kohei; Lee, Jeeyun